|
|
|
|
| Join us for an engaging Drug Delivery Leader Live. Explore FDA guidance on Essential Drug Delivery Outputs (EDDOs) with practical tips and expert insights. This interactive session covers implementation strategies and key recommendations for optimizing delivery outputs in product design, development, and regulatory planning for combination products and delivery systems. Don’t miss this opportunity to enhance your understanding and refine your approach. Register today! |
|
|
|
|
By Drug Delivery Leader: Supplier Horizons | Along with the goal of moving a wider range of biologics-based therapies into self-administered, in-home scenarios comes the challenge of delivering increased dosage volumes and higher viscosities via subcutaneous and transdermal methods. In this episode of Supplier Horizons, host Tom von Gunden talks with Stevanato Group’s President, Americas, Riccardo Butta about the convergence of human factors and device design during platform development for injectable and on-body delivery systems. | |
|
|
|
|
|
| Nanoformed API: A Superior Alternative To Solid Dispersions | Article | By Dr. Tamas Solymosi, Nanoform | Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens. |
|
|
|
|
| Combining Gene Therapies, Carrier Systems, And Medical Devices | Article | By Stefanie Johns, Ph.D., Kymanox Corporation | Drug delivery is one of the most significant obstacles to advancing gene therapies. Examine the opportunities for success in combining novel medical devices to improve delivery of gene therapies. |
|
|
|
|
|
|
|
|
.png){kind=logo}
